Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Oct 25 - Oct 30
In the SURMOUNT-1 trial with 2,539 adults with obesity, participants on the highest tirzepatide dose (15 mg weekly) lost an average of 20.9% of their body weight over 72 weeks
Current medications like Ozempic or Zepbound only hit one or two of those pathways, which is likely why early data is showing more dramatic results. New research on retatrutide benefits for weight loss According to NBC News , the newest phase 3 clinical trial found that people taking retatrutide lost up to 85 pounds, essentially 30 percent of their body weight, which is not too dissimilar to the percentage of body weight people lose after bariatric surgery, which is 25 to 35 percent within one to two years, per NBC News referencing data from Circulation Research
Avianne Bunnells medical expertise guiding your care, you can feel confident knowing your treatment is customized to your unique body, lifestyle, and wellness goals
One important regulatory update to know is that in December 2024, the FDA confirmed that the tirzepatide shortage had been resolved [1]
Hemolytic activity of nanoparticles as a marker of their hemocompatibility
US$ 24.68
US$ 25.38
US$ 22.93
US$ 21.92
